Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-01-16

FDA Approved: REMIFENTANIL HYDROCHLORIDE — Original Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved an original application for remifentanil hydrochloride from Fresenius Kabi USA, LLC as a generic injectable analgesic for anesthesia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • REMIFENTANIL HYDROCHLORIDE (REMIFENTANIL HYDROCHLORIDE)

Snippet

ORIG AP for REMIFENTANIL HYDROCHLORIDE (REMIFENTANIL HYDROCHLORIDE)